Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA.

IF 28.4 1区 医学 Q1 PATHOLOGY Annual Review of Pathology-Mechanisms of Disease Pub Date : 2021-01-24 Epub Date: 2020-11-23 DOI:10.1146/annurev-pathmechdis-012419-032604
Jonathan C Dudley, Maximilian Diehn
{"title":"Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA.","authors":"Jonathan C Dudley,&nbsp;Maximilian Diehn","doi":"10.1146/annurev-pathmechdis-012419-032604","DOIUrl":null,"url":null,"abstract":"<p><p>Because cancer is caused by an accumulation of genetic mutations, mutant DNA released by tumors can be used as a highly specific biomarker for cancer. Although this principle was described decades ago, the advent and falling costs of next-generation sequencing have made the use of tumor DNA as a biomarker increasingly practical. This review surveys the use of cellular and cell-free DNA for the detection of cancer, with a focus on recent technological developments and applications to solid tumors. It covers (<i>a</i>) key principles and technology enabling the highly sensitive detection of tumor DNA; (<i>b</i>) assessment of tumor DNA in plasma, including for genotyping, minimal residual disease detection, and early detection of localized cancer; (<i>c</i>) detection of tumor DNA in body cavity fluids, such as urine or cerebrospinal fluid; and (<i>d</i>) challenges posed to the use of tumor DNA as a biomarker by the phenomenon of benign clonal expansions.</p>","PeriodicalId":50753,"journal":{"name":"Annual Review of Pathology-Mechanisms of Disease","volume":"16 ","pages":"199-222"},"PeriodicalIF":28.4000,"publicationDate":"2021-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1146/annurev-pathmechdis-012419-032604","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annual Review of Pathology-Mechanisms of Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1146/annurev-pathmechdis-012419-032604","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/11/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 14

Abstract

Because cancer is caused by an accumulation of genetic mutations, mutant DNA released by tumors can be used as a highly specific biomarker for cancer. Although this principle was described decades ago, the advent and falling costs of next-generation sequencing have made the use of tumor DNA as a biomarker increasingly practical. This review surveys the use of cellular and cell-free DNA for the detection of cancer, with a focus on recent technological developments and applications to solid tumors. It covers (a) key principles and technology enabling the highly sensitive detection of tumor DNA; (b) assessment of tumor DNA in plasma, including for genotyping, minimal residual disease detection, and early detection of localized cancer; (c) detection of tumor DNA in body cavity fluids, such as urine or cerebrospinal fluid; and (d) challenges posed to the use of tumor DNA as a biomarker by the phenomenon of benign clonal expansions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
细胞和非细胞肿瘤DNA的检测和诊断应用。
由于癌症是由基因突变的积累引起的,肿瘤释放的突变DNA可以作为癌症的高度特异性生物标志物。虽然这个原理在几十年前就被描述过,但随着下一代测序技术的出现和成本的下降,肿瘤DNA作为生物标志物的使用越来越实用。本文综述了细胞和游离细胞DNA在癌症检测中的应用,重点介绍了最近的技术发展及其在实体肿瘤中的应用。它涵盖了(a)实现肿瘤DNA高灵敏度检测的关键原理和技术;(b)评估血浆中的肿瘤DNA,包括基因分型、最小残留疾病检测和局部癌症的早期检测;(c)检测体腔液体(如尿液或脑脊液)中的肿瘤DNA;(d)良性克隆扩增现象给肿瘤DNA作为生物标志物的使用带来的挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
62.60
自引率
0.00%
发文量
40
期刊介绍: The Annual Review of Pathology: Mechanisms of Disease is a scholarly journal that has been published since 2006. Its primary focus is to provide a comprehensive overview of recent advancements in our knowledge of the causes and development of significant human diseases. The journal places particular emphasis on exploring the current and evolving concepts of disease pathogenesis, as well as the molecular genetic and morphological changes associated with various diseases. Additionally, the journal addresses the clinical significance of these findings. In order to increase accessibility and promote the broad dissemination of research, the current volume of the journal has transitioned from a gated subscription model to an open access format. This change has been made possible through the Annual Reviews' Subscribe to Open program, which allows all articles published in this volume to be freely accessible to readers. As part of this transition, all articles in the journal are published under a Creative Commons Attribution (CC BY) license, which encourages open sharing and use of the research.
期刊最新文献
Challenges and Opportunities in the Clinical Translation of High-Resolution Spatial Transcriptomics. RNA Damage Responses in Cellular Homeostasis, Genome Stability, and Disease. Circadian Clocks, Daily Stress, and Neurodegenerative Disease Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward Pathogenesis of Germinal Matrix Hemorrhage: Insights from Single-Cell Transcriptomics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1